Drug Landscape ›
PO Acetaminophen ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 8
Most-reported reactions
Blood Pressure Increased — 1 report (12.5%) Chest X-Ray Abnormal — 1 report (12.5%) Chills — 1 report (12.5%) Dyspnoea — 1 report (12.5%) Heart Rate Increased — 1 report (12.5%) Infusion Related Reaction — 1 report (12.5%) Leukocytosis — 1 report (12.5%) Pyrexia — 1 report (12.5%)
Source database →
PO Acetaminophen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is PO Acetaminophen approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for PO Acetaminophen in United States?
Corewell Health West is the originator. The local marketing authorisation holder may differ — check the official source linked above.